BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Escalante P, Peikert T, Van Keulen VP, Erskine CL, Bornhorst CL, Andrist BR, McCoy K, Pease LR, Abraham RS, Knutson KL, Kita H, Schrum AG, Limper AH. Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk Stratification. Am J Respir Crit Care Med 2015;192:605-17. [PMID: 26030344 DOI: 10.1164/rccm.201412-2141OC] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Poloni C, Schonhofer C, Ivison S, Levings MK, Steiner TS, Cook L. T-cell activation-induced marker assays in health and disease. Immunol Cell Biol 2023. [PMID: 36825901 DOI: 10.1111/imcb.12636] [Reference Citation Analysis]
2 Chin KL, Anibarro L, Sarmiento ME, Acosta A. Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection. Trop Med Infect Dis 2023;8. [PMID: 36828505 DOI: 10.3390/tropicalmed8020089] [Reference Citation Analysis]
3 Robison HM, Chapman CA, Zhou H, Erskine CL, Theel E, Peikert T, Lindestam Arlehamn CS, Sette A, Bushell C, Welge M, Zhu R, Bailey RC, Escalante P. Risk assessment of latent tuberculosis infection through a multiplexed cytokine biosensor assay and machine learning feature selection. Sci Rep 2021;11:20544. [PMID: 34654869 DOI: 10.1038/s41598-021-99754-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
4 Escalante P, Arias-guillén M, Palacios Gutiérrez JJ. New research strategies in latent tuberculosis infection. Archivos de Bronconeumología (English Edition) 2021;57:151-153. [DOI: 10.1016/j.arbr.2020.01.011] [Reference Citation Analysis]
5 Rahimian A, Siltanen C, Feyzizarnagh H, Escalante P, Revzin A. Microencapsulated Immunoassays for Detection of Cytokines in Human Blood. ACS Sens 2019;4:578-85. [PMID: 30776214 DOI: 10.1021/acssensors.8b01033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
6 Sauzullo I, Mengoni F, Mascia C, Pavone P, Savelloni G, Massetti AP, Lichtner M, Vullo V, Mastroianni CM. Diagnostic performance in active TB of QFT-Plus assay and co-expression of CD25/CD134 in response to new antigens of Mycobacterium tuberculosis. Med Microbiol Immunol 2019;208:171-83. [PMID: 30623240 DOI: 10.1007/s00430-018-00576-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Behinaein P, Cirillo JD. The Silent Plague: Regulation of Latent Tuberculosis Infections. Tuberculosis Host-Pathogen Interactions 2019. [DOI: 10.1007/978-3-030-25381-3_2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Ramos GP, Stroh G, Al-Bawardy B, Faubion WA, Papadakis KA, Escalante P. Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy. Inflamm Bowel Dis 2018;24:2272-7. [PMID: 29718223 DOI: 10.1093/ibd/izy133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
9 Theel ES, Hilgart H, Breen-Lyles M, McCoy K, Flury R, Breeher LE, Wilson J, Sia IG, Whitaker JA, Clain J, Aksamit TR, Escalante P. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers. J Clin Microbiol 2018;56:e00614-18. [PMID: 29743310 DOI: 10.1128/JCM.00614-18] [Cited by in Crossref: 49] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
10 Koenig SP, Furin J. Update in Tuberculosis/Pulmonary Infections 2015. Am J Respir Crit Care Med 2016;194:142-6. [PMID: 27420359 DOI: 10.1164/rccm.201601-0129UP] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
11 Pennington K, Sasieta HC, Ramos GP, Erskine CL, Van Keulen VP, Peikert T, Escalante P. Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis. Clin Med Insights Case Rep 2017;10:1179547617724776. [PMID: 28890660 DOI: 10.1177/1179547617724776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Panteleev AV, Nikitina IY, Burmistrova IA, Kosmiadi GA, Radaeva TV, Amansahedov RB, Sadikov PV, Serdyuk YV, Larionova EE, Bagdasarian TR, Chernousova LN, Ganusov VV, Lyadova IV. Severe Tuberculosis in Humans Correlates Best with Neutrophil Abundance and Lymphocyte Deficiency and Does Not Correlate with Antigen-Specific CD4 T-Cell Response. Front Immunol 2017;8:963. [PMID: 28871253 DOI: 10.3389/fimmu.2017.00963] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
13 Halliday A, Whitworth H, Kottoor SH, Niazi U, Menzies S, Kunst H, Bremang S, Badhan A, Beverley P, Kon OM, Lalvani A. Stratification of Latent Mycobacterium tuberculosis Infection by Cellular Immune Profiling. J Infect Dis 2017;215:1480-7. [PMID: 28329119 DOI: 10.1093/infdis/jix107] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
14 Dan JM, Lindestam Arlehamn CS, Weiskopf D, da Silva Antunes R, Havenar-Daughton C, Reiss SM, Brigger M, Bothwell M, Sette A, Crotty S. A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood. J Immunol 2016;197:983-93. [PMID: 27342848 DOI: 10.4049/jimmunol.1600318] [Cited by in Crossref: 141] [Cited by in F6Publishing: 153] [Article Influence: 20.1] [Reference Citation Analysis]